Fibroblasts might be necessary, too, as treatment of cancer-associated fibroblasts with IL-1β significantly enhanced their ability to inhibit CD8+ T cell function and proliferation [47], which was mediated by upregulation of PD-L1/2. The gene discussed is IL1B; the disease is cancer.